ArticleScientific reports2026
Prevalence, types, and demographic characteristics associated with major life changes following psychedelic use.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Aha! Glow: Insight Experiences Bias Judgements of Idea Quality in Divergent Contexts.Journal of Intelligence · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Psychedelic use has been linked to major life changes that may impact health outcomes, yet few studies have systematically examined the prevalence, types, and demographic characteristics that may be associated with such changes. This paper draws subsamples of respondents who endorsed lifetime psychedelic use from two samples of US adults - one nationally representative by age, race/ethnicity, and sex (Study 1; n = 613) and one larger, more sociodemographically diverse but non-representative (Study 2; n = 3,168). Study 1 was used to estimate the prevalence of reported major life changes following psychedelic use and to characterize the types of changes reported; Study 2 was used to extend the findings from Study 1 by exploring demographic characteristics that might be associated with the likelihood of experiencing major life changes following psychedelic use. In Study 1, 18.4% of respondents (n = 113) reported at least one major life change that they attributed to psychedelic use, with common changes involving relationships (6.9%, n = 42); diet and exercise (6.2%, n = 38); quitting alcohol, tobacco, or other substance use (5.5%, n = 34), and religious beliefs (5.5%, n = 34). In Study 2, higher religiosity, younger age, and greater lifetime psychedelic use emerged as factors strongly associated with reporting a major life change following psychedelic use (aORs > 3.0, p < 0.001 for all). These findings suggest that major life changes following psychedelic use occur in approximately 1 in 5 users and may vary by demographic factors. Further research using longitudinal designs is warranted to clarify the persistence, valence, and health impact of such changes and to guide evidence-based approaches to preparation, integration, and support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.